Defining the immune cascade leading to Nod-like receptor mediated Type 2 immune responses
Defining the immune cascade leading to Nod-like receptor mediated Type 2 immune responses
批准号:
198700620
负责人:
Dr. Claudia Dürr
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2011
资助国家:
德国
项目状态:
未结题
起止时间:
2010-12-31 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Progress for the control of infectious diseases can only be achieved on the basis of our increasing insights into the complex host defence mechanisms. Recent observations have led to the discovery of several host protein families, referred to as pattern recognition molecules including the families of the Toll-like and Nod-like receptors. These host defence proteins specifically detect molecular patterns of pathogens as well as infection-induced physiological changes of infected host cells, suggesting a critical role for their function in regulating antimicrobial immunity. The present project focuses on deciphering the mechanisms of how the mammalian immune system recognizes pathogens leading to the subsequent instruction of long-lived immune responses. In my outlined project I will specifiically aim to charcaterize the immune cascade leading to Nod-like receptor triggered type 2 immune responses and to dissect the soluble mediators involved to induce this immune effector arm. I will (i) define the innate source(s) of IL-4 and IL-13 upon Nod1- and Nod2-mediated pathogen recognition, and examine the involvement of IL-25 and IL-33 for the priming of type 2 immunity, (ii) study the protective role of Nod1- and Nod2-driven type 2 immunity in a gastrointestinal infection model in vivo, and (iii) investigate the involvement of stem cell factor mediated c-kit signalling in Nod1- and Nod2-mediated immune responses. The scientific insights gained from the proposed research program will advance our medical and scientific knowledge, which will enable us to tailor preventive vaccination strategies to combat infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mysm1 is a decision checkpoint regulator of Group2 innate lymphoid cell biology
-
批准号:428195095
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Dr. Claudia Dürr
-
依托单位:
国内基金
海外基金
登录
查看更多内容
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
-
批准号:82371791
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘永波
-
依托单位:
T细胞受体NRP1作为新型免疫检查点在去势抵抗性前列腺癌中的作用机制研究
-
批准号:32100631
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘飞
-
依托单位:
抑制FGF19/FGFR4信号通路促进肺鳞癌细胞焦亡及免疫增效的机制研究
-
批准号:32100565
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李凡
-
依托单位:
间充质干细胞通过CD73/CD39/腺苷-PI3K/Akt-Nrf2信号轴调节CD4+IL-10+IFN-γ+T细胞分化减弱GVHD机制研究
-
批准号:32070781
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:栾希英
-
依托单位:
自噬基因Epg5在诺如病毒感染过程中的作用
-
批准号:32070745
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:路群
-
依托单位:
C9ORF72-SMCR8复合物在小胶质细胞中的功能及其介导的炎症反应
-
批准号:32070743
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:杨玫
-
依托单位:
MET通过MTOR介导的自噬调节肝癌免疫原性和治疗抗性的作用及机制研究
-
批准号:31970696
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:黄星
-
依托单位: